"It's actually terrifying that he can't remember what has transpired," says Penikett, who plays damaged hero Maj. Tom Cafferty. "He has lost a big section of his memory, a whole time period. He's trying to figure it out bit by bit. And for a guy who is used to be in control and on top of it and in charge of his faculties, to have his memory gone like that makes him feel very vulnerable." Painkillers mixes psychology, conspiracies and science fiction, grounding it all in more topical concerns about the traumatic effects of war.
My opinion: This sounds like a pretty interesting story.
The series premiered March 30, attracting the biggest audience for an original series debut in Space’s 15-year history – and some excellent reviews. “Thoroughly impressive, wildly entertaining,” gushed The Hollywood Reporter. “One of the most intriguingly entertaining new series of the year.”
Much has also been made of its ambiguous setting. For example, what appear to be suburban trains in the opening sequence are departing for New York, but the dead woman’s wallet is filled with Canadian currency. “It’s meant to be Generica,” says Manson. “It’s part of the price you pay for this kind of co-production.”
My opinion: I only saw a little bit of the shows Contiuum, Lost Girl, and Orphan Black. They seem pretty good. These kind of shows I have to watch from the beginning so I can follow it. It’s not like crime procedurals where you can watch a random episode here and there and you still know what’s going on.
Motive: “Show's writers search for a Motive” by Glen Schaefer. This is another Canadian TV show that has found success in Canada and the US. It’s published Dec. 14, 2013. Here’s an excerpt:They're looking for poisons that leave no trace. They want to know what a body looks like after it's been trampled to death by a horse.
"Based on our Google searches alone, we're probably up there on the most wanted list," said writer James Thorpe who, with colleague Dennis Heaton, shares the title of executive producer on the CTV mystery series Motive.